Liquid biopsy as a new era in endometrial cancer

dc.authoridYALCINTEPE, Sinem/0000-0002-8557-8885
dc.contributor.authorZhuri, Drenushe
dc.contributor.authorYalcintepe, Sinem
dc.date.accessioned2024-06-12T11:00:24Z
dc.date.available2024-06-12T11:00:24Z
dc.date.issued2024
dc.departmentTrakya Üniversitesien_US
dc.description.abstractEndometrial cancer (EC) is one of the most frequent invasive cancers of the female genital tract, and despite the rising incidence of EC worldwide and the poor overall survival of patients, no viable blood-based biomarker exists to detect and track EC recurrence during routine follow-up. Identification of new genetic targets and biomarkers linked to enhanced recurrence risk and medication response is a primary clinical issue in the treatment of advanced endometrial cancer. In this regard, liquid biopsy has become a breakthrough in human cancers. A liquid biopsy blood test has the advantage of being more sensitive than traditional imaging and is a minimally invasive complement to needle or excision biopsies of tissue. Here in this article, we discussed the advances and limitations of liquid biopsy. The detection of biomarkers and variations in liquid biopsy may help the diagnostic process of endometrial cancer cases.en_US
dc.identifier.doi10.1515/oncologie-2024-0036
dc.identifier.endpage486en_US
dc.identifier.issn1292-3818
dc.identifier.issn1765-2839
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-85194485908en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage483en_US
dc.identifier.urihttps://doi.org/10.1515/oncologie-2024-0036
dc.identifier.urihttps://hdl.handle.net/20.500.14551/20809
dc.identifier.volume26en_US
dc.identifier.wosWOS:001205282600001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherWalter De Gruyter Gmbhen_US
dc.relation.ispartofOncologieen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectEndometrial Canceren_US
dc.subjectLiquid Biopsyen_US
dc.subjectCfdnaen_US
dc.subjectBiomarkersen_US
dc.subjectExpressionen_US
dc.subjectL1camen_US
dc.titleLiquid biopsy as a new era in endometrial canceren_US
dc.typeEditorialen_US

Dosyalar